Log in to save to my catalogue

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influen...

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bc44bb79022a4c71bb9265d1431e6add

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influenza in Chickens

About this item

Full title

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influenza in Chickens

Publisher

Switzerland: MDPI AG

Journal title

Viruses, 2020-12, Vol.12 (12), p.1407

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Control measures in the case of high pathogenicity avian influenza (HPAI) outbreaks in poultry include culling, surveillance, and biosecurity; wild birds in captivity may also be culled, although some rare bird species should be rescued for conservation. In this study, two anti-influenza drugs, baloxavir marboxil (BXM) and peramivir (PR), used in h...

Alternative Titles

Full title

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influenza in Chickens

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_bc44bb79022a4c71bb9265d1431e6add

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bc44bb79022a4c71bb9265d1431e6add

Other Identifiers

ISSN

1999-4915

E-ISSN

1999-4915

DOI

10.3390/v12121407

How to access this item